Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Arbor Realty Trust F Pref | ABR-F | Oct 17, 2024 | 19.80 | +0.97 |
Arbutus Biopharma | ABUS | Oct 17, 2024 | 4.12 | -1.90 |
ARC Document Solutions | ARC | Oct 17, 2024 | 3.41 | -0.29 |
Arcadia Biosciences | RKDA | Oct 17, 2024 | 3.18 | +14.39 |
Arcadium Lithium | ALTM | Oct 17, 2024 | 5.53 | 0.00 |
ArcBest | ARCB | Oct 17, 2024 | 104.89 | -1.34 |
Arcellx | ACLX | Oct 17, 2024 | 95.27 | +2.44 |
Arcelor Mittal ADR | MT | Oct 17, 2024 | 23.89 | -0.67 |
Arch Capital F Pref | ACGLO | Oct 17, 2024 | 23.58 | -0.08 |
Arch Capital G | ACGLN | Oct 17, 2024 | 20.67 | -0.14 |
Arch Capital Group | ACGL | Oct 17, 2024 | 108.25 | +0.73 |
Arch Resources A | ARCH | Oct 17, 2024 | 142.46 | -1.87 |
Archer Aviation A | ACHR | Oct 17, 2024 | 3.19 | 0.00 |
Archer Daniels Midland | ADM | Oct 17, 2024 | 58.63 | +0.58 |
Archrock | AROC | Oct 17, 2024 | 21.11 | -1.68 |
Arcos Dorados | ARCO | Oct 17, 2024 | 9.53 | -1.85 |
Arcosa | ACA | Oct 17, 2024 | 96.23 | -0.30 |
Arcturus Therapeutics | ARCT | Oct 17, 2024 | 20.60 | -0.15 |
Arcus Biosciences | RCUS | Oct 17, 2024 | 18.24 | +2.13 |
Arcutis Biotherapeutics | ARQT | Oct 17, 2024 | 9.49 | -2.37 |
Ardagh Metal Packaging | AMBP | Oct 17, 2024 | 4.14 | +4.28 |
Ardelyx | ARDX | Oct 17, 2024 | 5.83 | -0.34 |
Ardent Health Partners | ARDT | Oct 17, 2024 | 19.50 | 0.00 |
Ardmore Shipping | ASC | Oct 17, 2024 | 16.70 | +0.12 |
Ares Acquisition II | AACT | Oct 17, 2024 | 10.85 | +0.14 |
Ares Capital | ARCC | Oct 17, 2024 | 21.58 | +0.05 |
Ares Commercial Real Estate | ACRE | Oct 17, 2024 | 6.67 | -1.77 |
Ares Dynamic Credit Allocation Fund | ARDC | Oct 17, 2024 | 15.31 | -0.20 |
Ares Management A | ARES | Oct 17, 2024 | 168.73 | +3.21 |
Argan | AGX | Oct 17, 2024 | 129.10 | -0.14 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.